Clinical Trial Detail

NCT ID NCT02520154
Title Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

ovarian cancer

Therapies

Carboplatin + Paclitaxel

Pembrolizumab

Age Groups: adult

No variant requirements are available.